BioCentury
ARTICLE | Clinical News

Vector that carries the gene for thymidine kinase: Protocol for a Phase I/II trial approved

December 6, 1993 8:00 AM UTC

Genetic Therapy Inc. (GTII) Product: Vector that carries the gene for thymidine kinase, which renders targeted cancer cells susceptible to the anti-viral drug ganciclovir Indication: Leptomeningeal ca...